| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.11B | -2.9% |
| R&D Expense | $143.0M | +31.2% |
| SG&A Expense | $936.0M | +12.6% |
| Operating Income | -$792.0M | -14.9% |
| Interest Expense | $702.0M | +13.0% |
| Pre-tax Income | -$1.39B | +5.9% |
| Income Tax | $154.0M | +3180.0% |
| Net Income | $1.83B | +290.6% |
| EPS (Basic) | $2.40 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.31B | +240.4% |
| Accounts Receivable | $267.0M | +32.2% |
| Inventory | $28.0M | +27.3% |
| Current Assets | $6.74B | +22.4% |
| Total Assets | $22.04B | +9.9% |
| Current Liabilities | $3.90B | +52.1% |
| Long-term Debt | $13.95B | -5.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $651.0M | -21.4% |
| +290.5% |
| EPS (Diluted) | $2.40 | +290.5% |
| Total Liabilities |
| $18.38B |
| +3.2% |
| Stockholders' Equity | $3.88B | +94.4% |